Synthetic Biology Market worth $5,630.4 Million by 2018

1
MarketsandMarkets Presents
Synthetic Biology Market worth 5,630.4 Million
by 2018
http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
2
The report Synthetic Biology Market by Tool(XNA,
Chassis, Oligos, Enzymes, Cloning kits), By
Technology (Bioinformatics, Nanotechnology, Gene
Synthesis, Cloning Sequencing), By Application
(Biofuels, Pharmaceuticals, Biomaterials,
Bioremediation) - Global Forecast to 2018,
analyzes and studies the major market drivers,
threats, opportunities, and challenges. Browse
99 market data tables and 46 figures spread
through 185 pages and in-depth TOC on "Synthetic
Biology Market by Tool(XNA, Chassis, Oligos,
Enzymes, Cloning kits), By Technology
(Bioinformatics, Nanotechnology, Gene Synthesis,
Cloning Sequencing), By Application (Biofuels,
Pharmaceuticals, Biomaterials, Bioremediation) -
Global Forecast to 2018 http//www.marketsandmar
kets.com/Market-Reports/synthetic-biology-market-8
89.html
 
http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
3
Early buyers will receive 10 customization on
this report.

 
http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
4

• This report studies the global synthetic biology
  market for the forecast period of 2013 to 2018.
  This market is expected to reach 5,630.4 million
  by 2018 from 1,923.1 million in 2013, growing at
  a CAGR of 24 during the forecast period.
• The global synthetic biology market is segmented
  on the basis of tools, technologies,
  applications, and geographies.
• On the basis of tools, the synthetic biology
  market is categorized into Xeno-nucleic acids,
  chassis organisms, oligonucleotides, enzymes, and
  cloning and assembly kits. The oligonucleotides
  segment accounted for a major share of the
  synthetic biology market, by tool, in 2013.

http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
5

• On the basis of technologies, the synthetic
  biology market is segmented into enabled and
  enabling technologies. Enabling technologies
  accounted for a major share of the synthetic
  biology market in 2013. On the basis of
  applications, the synthetic biology market is
  segmented into environmental, medical, and
  industrial applications. The medical applications
  segment accounted for a major share of the
  synthetic biology market in 2013.
• On the basis of regions, the market is divided
  into North America, Europe, Asia, and Rest of the
  World (RoW). The Rest of the World region
  comprises Latin America, Pacific countries, and
  Middle East and Africa. North America accounted
  for the largest share of the synthetic biology
  market, followed by Europe and Asia. However, the
  European market is expected to grow at the
  highest CAGR in the coming five years, and serves
  as a revenue pocket for the companies involved in
  the manufacturing of synthetic biology products.

http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
6

• Over the years, the demand for synthetic biology
  is likely to increase owing to the increasing RD
  expenditure in pharmaceutical and biotechnology
  companies, growing demand for synthetic genes,
  rising production of genetically modified crops,
  and incessantly rising funding in the field of
  synthetic biology. However, ethical and social
  issues such as biosafety and biosecurity are
  major factors that are restricting the growth of
  this market. Furthermore, rising concerns over
  fuel consumption and increasing demand for
  protein therapeutics are likely to create
  opportunities for the synthetic biology market.
  However, standardization and integration of
  biological parts at system-level still remains a
  challenge for this market.

http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
7

• Some of the major players in the global synthetic
  biology market include Amyris, Inc. (U.S.),
  DuPont (U.S.), GenScript USA, Inc. (U.S.),
  Intrexon Corporation (U.S.), Integrated DNA
  Technologies (IDT) (U.S.), New England Biolabs,
  Inc. (NEB) (U.S.), Novozymes (Denmark), Royal DSM
  (Netherlands), Synthetic Genomics, Inc.
  (California), and Thermo Fisher Scientific, Inc.
  (U.S.).

http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
8
Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html
9
About MarketsandMarkets
MarketsandMarkets is the global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. MMs flagship competitive intelligence
and market research platform, "RT" connects over
200,000 markets and entire value chains for
deeper understanding of the unmet insights along
with market sizing and forecasts of niche
markets. The new included chapters on Methodology
and Benchmarking presented with high quality
analytical infographics in our reports gives
complete visibility of how the numbers have been
arrived and defend the accuracy of the
numbers. We at MarketsandMarkets are inspired
to help our clients grow by providing apt
business insight with our huge market
intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/sy
nthetic-biology-market-889.html